Tandem Diabetes Care
TNDM
TNDM
272 hedge funds and large institutions have $2.77B invested in Tandem Diabetes Care in 2023 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 116 increasing their positions, 92 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 294 → 272 (-22)
36% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 53
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
272
Holding in Top 10
1
Calls
$9.71M
Puts
$4.3M
Top Buyers
| 1 | +$116M | |
| 2 | +$44.9M | |
| 3 | +$37.4M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$33.6M |
| 5 |
Morgan Stanley
New York
|
+$18.5M |
Top Sellers
| 1 | -$56.9M | |
| 2 | -$39.6M | |
| 3 | -$16.2M | |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$14.4M |
| 5 |
Axa
Paris,
France
|
-$13.7M |